Recent Business Proposals in Medical & Sciences - Australia and International

The Medical Device sector is experiencing challenges licensing its products for sale. Growth in demand for eClinical technology driven by regulations and healthcare demand is creating an opportunity for Clindox in a market that is underserved.

• Our SaaS eClinical platform is market proven with 21 repeat customers
• The Clindox Management team has >150 years experience in the market

Ostara is developing innovative solutions to tackle human infertility. The first is Evie™, a clinical use, automatic slow-release insemination device which acts over 4 hours and results in significantly higher pregnancy rates.

• Clinical trial has confirmed significant increase in pregnancy rates
• Very positive feedback from key opinion leaders and patients

Updated: Mantra Medical develops infection control devices to integrate seamlessly into patient care. The use of automation and an understanding of healthcare workflow means we can target everyday patient interactions without increasing staff work.

• Targets unaddressed niche in $258bn global infection control market
• Production LOI from global manufacturing partner with 27,000 employees

A new, exciting and innovative Radio Frequency technology for the treatment of soft tissue tumours will expand the number of patients being treated with a minimally invasive procedure.

• Fully workable generator in the midst of final safety testing
• Close to commecning final clinical program and first in man study

Biotech company with validated interest already secured from potential exit partners and eloquent life science VCs. OUR STRATEGIC AIM To bring the world's first ever disease-modifying therapeutic for EBS to the market

• Validated interest from 4 leading rare/dermatology exit targets
• Validated interest from multiple eloquent life science investors

Nordics are well structured when it comes to pharmaceutical distribution but being a relatively smaller consumer market, patients often suffer due to regular stockouts. We specialize in filling in those gaps by providing EU approved medicines.

• 24000 packs sold in 2021.
• 3.1 million DKK sales achieved in 2021.
• above 90% success rate in finding substitute medicines from EU sources.

Filisia is an innovator in technology for people with Special Educational Needs and Disabilities (SEND). Through Cosmo, its unique award-winning system, we are creating a world of inclusive learning, therapy and play between school and the home.

• Cosmo game changes inclusive learning, therapy and play for SEND
• Tried, tested and validated product. Established and ready to scale

Dignify personal liquid storage system, supports urinary tract and pressure care management. This new technology is discrete with no visual tubes or bags. Increasing comfort, independence, dignity and mobility, to significant improvement client care.

• Greatly increase level of dignity - independence and mobility
• Environmentally friendly - sustainable economic growth

COVID is the #1 Public Health threat today. Current vaccines protect against most SARS-2 strains, but new mutants such as the Delta and South African strain can evade vaccine antibodies. The technology is designed to protect against any mutant strain

• Huge market potential
• Pressing unmet need
• Patent applied for, founder has 6 patents awarded